Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | Novavax, Inc. NVAX |
BLACKROCK INC BLK |
13,450,411 8.400% |
5,014,232 (+59.44%) |
Filing History |
| 2024-11-12 4:46 pm Unchanged |
2024-09-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 15,430,034 9.630% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:19 pm Purchase |
2024-09-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 15,430,034 9.630% |
869,980 (+5.98%) |
Filing History |
| 2024-07-10 06:16 am Sale |
2024-06-30 | 13G | Novavax, Inc. NVAX |
STATE STREET CORP STT |
6,066,179 4.320% |
-10,709,696 (-63.84%) |
Filing History |
| 2024-06-20 2:35 pm Unchanged |
2024-05-10 | 13G | Novavax, Inc. NVAX |
SK Bioscience Co. Ltd. | 6,500,000 4.600% |
0 (Unchanged) |
Filing History |
| 2024-05-20 06:09 am Purchase |
2024-05-20 | 13D | Arbutus Biopharma Corporation ABUS |
Shah Capital Management | 11,031,176 7.900% |
11,031,176 (New Position) |
Filing History |
| 2024-05-07 2:43 pm Purchase |
2024-05-06 | 13D | Novavax, Inc. NVAX |
Shah Capital Management | 10,766,176 7.700% |
1,382,841 (+14.74%) |
Filing History |
| 2024-04-15 12:18 pm Unchanged |
2024-04-10 | 13D | Novavax, Inc. NVAX |
Shah Capital Management | 9,383,335 6.700% |
0 (Unchanged) |
Filing History |
| 2024-04-15 06:00 am Purchase |
2024-04-10 | 13D | Novavax, Inc. NVAX |
Shah Capital Management | 9,383,335 6.700% |
4,832,579 (+106.19%) |
Filing History |
| 2024-03-07 4:34 pm Sale |
2024-02-29 | 13G | Novavax, Inc. NVAX |
MORGAN STANLEY MS |
2,454,328 1.800% |
-4,853,705 (-66.42%) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 14,560,054 12.260% |
5,715,401 (+64.62%) |
Filing History |
| 2024-02-09 1:59 pm Purchase |
2023-12-31 | 13G | Novavax, Inc. NVAX |
MORGAN STANLEY MS |
7,308,033 6.200% |
7,308,033 (New Position) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Novavax, Inc. NVAX |
BLACKROCK INC BLK |
8,436,179 7.100% |
3,627,918 (+75.45%) |
Filing History |
| 2024-01-25 08:57 am Purchase |
2023-12-31 | 13G | Novavax, Inc. NVAX |
STATE STREET CORP STT |
16,775,875 14.120% |
6,323,363 (+60.50%) |
Filing History |
| 2023-08-18 06:08 am Purchase |
2023-08-08 | 13G | Novavax, Inc. NVAX |
SK Bioscience Co. Ltd. | 6,500,000 6.400% |
6,500,000 (New Position) |
Filing History |
| 2023-05-10 09:10 am Purchase |
2023-04-30 | 13G | Novavax, Inc. NVAX |
STATE STREET CORP STT |
10,452,512 12.110% |
4,375,994 (+72.01%) |
Filing History |
| 2023-04-27 2:52 pm Purchase |
2023-04-26 | 13D | Novavax, Inc. NVAX |
Shah Capital Management | 4,550,756 5.280% |
4,550,756 (New Position) |
Filing History |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Novavax, Inc. NVAX |
The Vanguard Group | 8,844,653 10.410% |
852,425 (+10.67%) |
Filing History |
| 2023-02-02 12:47 pm Purchase |
2022-12-31 | 13G | Novavax, Inc. NVAX |
STATE STREET CORP STT |
6,076,518 7.150% |
6,076,518 (New Position) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Novavax, Inc. NVAX |
BLACKROCK INC BLK |
4,808,261 5.700% |
397,500 (+9.01%) |
Filing History |